factor xi
Biologicalexperimental
Factor XI, or plasma thromboplastin antecedent, is the zymogen form of factor XIa, one of the enzymes involved in coagulation. Like many other coagulation factors, it is a serine protease. In humans, factor XI is encoded by F11 gene. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 3, 2012 (NCT01701947)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaFactor XI ↗
Also known as
- factor xi
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01701947 | N/A | Oct 3, 2012 | Laboratoire français de Fractionnement et de Biotechnologies, Vanderbilt University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Laboratoire français de Fractionnement et de Biotechnologies | For profit | 1 | 1 | 1 | 2012 |
| Vanderbilt University | Academic/Hospital | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1